Stevanato Group S.p.A STVN
NYSE STVN
$22.60 +0.25 (+1.12%)
At close: Aug 21, 2026 · 4:00 PM EDT

Stevanato Group S.p.A (STVN) Asset Writedowns and Impairment (2020 - 2026)

Stevanato Group S.p.A (STVN) posted quarterly Asset Writedowns and Impairment of -$151026.2 for Q1 2026, up 63.37% year-over-year from -$92442.4 in Q1 2025, and down 127.78% quarter-over-quarter from $543610.6 in Q3 2025.

Stevanato Group S.p.A (STVN) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends

Stevanato Group S.p.A (STVN) has reported Asset Writedowns and Impairment for 7 consecutive years, with -$151026.2 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Asset Writedowns and Impairment rose 63.37% year-over-year to -$151026.2; the TTM figure through Mar 2026 stood at $103629.3 (up 186.87% YoY), while the FY2021 annual figure was -$1.5 million, down 475.77% from the prior year.
  • Asset Writedowns and Impairment eased to -$151026.2 in Q1 2026 per STVN's latest filing, from $543610.6 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $746939.7 in Q2 2022 and bottomed at -$412338.7 in Q1 2025.
  • Historically, Asset Writedowns and Impairment has averaged $72880.2 across 5 years, with a median of -$59303.9 in 2024.
  • Annual changes were most pronounced in 2024 — Asset Writedowns and Impairment sank 492.82% — and 2025, when it soared 1016.65%.
  • Stevanato Group S.p.A's Asset Writedowns and Impairment stood at -$80661.9 in 2022, then slumped by 364.25% to -$374475.1 in 2023, then soared by 84.16% to -$59303.9 in 2024, then jumped by 1016.65% to $543610.6 in 2025, then sank by 127.78% to -$151026.2 in 2026.
  • Business Quant data shows STVN's Asset Writedowns and Impairment at -$151026.2 in Q1 2026, $543610.6 in Q3 2025, and $123383.6 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Stevanato Group S.p.A 6.18 Bn 6.07 Bn 100.91 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 282,453.93
Jun 30, 2026 282,453.93
Mar 31, 2026 -151,026.19
Mar 31, 2026 -151,026.19
Sep 30, 2025 543,610.62
Sep 30, 2025 543,610.62
Jun 30, 2025 123,383.61
Jun 30, 2025 123,383.61
Mar 31, 2025 -412,338.70
Mar 31, 2025 -412,338.70
Sep 30, 2024 -59,303.85
Sep 30, 2024 -59,303.85
Jun 30, 2024 575,057.97
Jun 30, 2024 575,057.97
Mar 31, 2024 -222,704.16
Mar 31, 2024 -222,704.16
Sep 30, 2023 -374,475.12
Sep 30, 2023 -374,475.12
Jun 30, 2023 358,256.12
Jun 30, 2023 358,256.12